Ultragenyx Pharmaceutical
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RARE and other ETFs, options, and stocks.About RARE
Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza.
RARE Key Statistics
Stock Snapshot
With a market cap of 2.22B, Ultragenyx Pharmaceutical(RARE) trades at $23.00. The stock has a price-to-earnings ratio of -3.87.
On 2026-01-02, Ultragenyx Pharmaceutical(RARE) stock traded between a low of $21.90 and a high of $23.25. Shares are currently priced at $23.00, which is +5.0% above the low and -1.1% below the high.
Ultragenyx Pharmaceutical(RARE) shares are trading with a volume of 3.67M, against a daily average of 4.67M.
During the past year, Ultragenyx Pharmaceutical(RARE) stock moved between $18.41 at its lowest and $46.50 at its peak.
During the past year, Ultragenyx Pharmaceutical(RARE) stock moved between $18.41 at its lowest and $46.50 at its peak.
RARE News
One analyst sees significant upside for the stock after yesterday's sell-off. While Ultragenyx Pharmaceutical (RARE +15.52%) provided the market with disappoin...
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares plunged 42% on Monday after the company and partner Mereo BioPharma Group plc (NASDAQ:MREO) disclosed disapp...
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and Mereo BioPharma Group plc (NASDAQ:MREO) stocks hit their 52-week low on Monday, as per data from Benzinga Pro....